COST Action CA18218

4th MC meeting & 3rd WG meeting

Date & Place

24-26 January 2022
Online event


Program

 Monday 24/01Tuesday 25/01Wednesday 26/01
13h00 MC meeting WG meeting: Action updates WG meeting: Abstract session
14h00  
15h00  
16h00      

Management Committee meeting (24/1, 13-15h CET)

During the Management Committee (MC) meeting, a general update of the progress of the COST Action will be presented, including an update of the budgetary status. The MC meeting is restricted to invited MC members and observers.

Working Group meeting, session 1 — Action updates (25/1, 13-16h CET)

This WG session will be dedicated to updates from the Action and different Working Groups. We will also give the floor to our members to learn about their needs and expectations. This WG session will be open to all members of the network.

13h00 Welcome & Presentation of COST action CA18218 burden-eu
— Brecht Devleesschauwer, Action Chair
Download the presentation
13h30 Training schools & Meetings
— Brecht Devleesschauwer, Action Chair
Download the presentation
14h00 Mobility and dissemination grants
— Tina Lesnik, Grant Awarding Coordinator
Download the presentation
14h15 Coffee break
14h25 Knowledge translation Working Group
— Henk Hilderink, WG5 leader
Download the presentation
14h50 COVID-19 disease burden Task Force
— Sara Pires, WG2 leader
Download the presentation
15h15 Activities and outputs of Working Groups
— Brecht Devleesschauwer, Action Chair, Juanita Haagsma, WP1 leader & Elena von der Lippe, WG4 leader
Download the presentation
15h45 What's next?
— Brecht Devleesschauwer, Action Chair
Download the presentation
16h00 Closure of Session 1

 

Working Group meeting, session 2 — Abstract session (26/1, 13-16h CET)

This WG session will be dedicated to Action members presenting abstracts. This WG session will be open to all members of the network.

13h00 Welcome
— Brecht Devleesschauwer, Action Chair, Sciensano, Belgium
Download the presentation
13h15 Estimating the direct Disability-Adjusted Life Years (DALYs) associated with SARS-CoV-2 (COVID-19) in the Republic of Ireland: The first full year
— Declan Moran, University College Cork, Ireland
Download the presentation
13h30 BoCO-19: The Burden of Disease due to COVID-19. Towards a harmonization of population health metrics for the surveillance of dynamic outbreaks
— Caoimhe Cawley, Robert Koch Institute, Germany
Download the presentation
13h45 The non-fatal burden of cancer in Belgium, 2004–2019
— Vanessa Gorasso, Sciensano, Belgium
Download the presentation
14h00 Assessing the burden due to non-communicable diseases and injuries: collation of data input sources
— Periklis Charalampous, Erasmus Medical Centre, Netherlands
Download the presentation
14h15 Coffee break
14h25 Differences between the registered and expected mortality in Serbia in 2020
— Aleksandar Stevanovic, University of Belgrade, Serbia
Download the presentation
14h40 Ill-defined deaths by age and sex in Belgrade population, 2016-2020
— Natasa Rosic, Institute of Public Health of the City of Belgrade, Serbia
Download the presentation
14h55 Temporal variation in the burden of ambient air pollution in Italy: an analysis from the Global Burden of Disease Study 1990-2019
— Sara Conti, Università degli Studi di Milano-Bicocca, Italy
Download the presentation
15h10 Assessing the environmental burden of disease due to road traffic noise in Hesse, Germany
— Matthias Lochmann, Hessian Agency for Nature Conservation, Environment and Geology, Germany
Download the presentation
15h25 Coffee break
15h35 Poster session
CATINCA - Capacities and infrastructures for health policy development in South Caucasus and Central Asia. Strengthening information systems for summary measures of population health
— Aline Anton, Robert Koch Institute, Germany
Tuberculosis Burden of Disease by Gender in Turkey Between 1990-2019: A Joinpoint Regression Analysis Study
— Ali Kılınç, Eskisehir Osmangazi University, Turkey
PMCardImpact: the health and economic impact of PM2.5-related cardiovascular diseases in Portugal
— Carla Martins, NOVA National School of Public Health, Portugal
Burden of breast, cervical and colorectal cancers in the countries of former Yugoslavia
— Jovana Todorovic, University of Belgrade - Serbia
Case study: Understanding the economic impact of COVID-19 on health systems
— Neil Chalmers, Public Health Scotland, UK
Disease burden of COVID-19 in Vojvodina, Serbia, from July 2020 to April 2021
— Tijana Lainovic, University of Novi Sad, Serbia 
Social and economic burden of chronic diseases in Bulgaria - a case with multiple sclerosis and asthma
— Zornitsa Mitkova, Medical University of Sofia, Bulgaria
15h55 What's next?
— Brecht Devleesschauwer, Action Chair, Sciensano, Belgium
16h00 Closure of Session 2

About COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Read more via cost.eu.

Get in touch

COST logo

Funded by the European Union

Website by  woluweb mini